Statins and SARS‐CoV‐2 Infection: Results of a Population‐Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces

Statins and SARS‐CoV‐2 Infection: Results of a Population‐Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces

Background Small observational studies have suggested that statin users have a lower risk of dying with COVID‐19. We tested this hypothesis in a large, population‐based cohort of adults in 2 of Canada’s most populous provinces: Ontario and Alberta. Methods and Results We examined reverse transcripta...

Full description

Bibliographic Details
Main Authors: Finlay A. McAlister, Ting Wang, Xuesong Wang, Anna Chu, Shaun G. Goodman, Sean van Diepen, Cynthia A. Jackevicius, Padma Kaul, Jacob Udell, Dennis T. Ko, Jeffrey C. Kwong, Peter C. Austin, Douglas S. Lee
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
COVID‐19
outcomes
SARS‐CoV‐2
statins
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.022330

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.022330

Similar Items